FIELD: chemistry.
SUBSTANCE: method is demonstrated on the scheme Method includes the following steps: (step 1) preparing a compound represented by chemical formula 4 by bonding a compound represented by chemical formula 2 and a compound represented by chemical formula 3 with peptide bond by reacting them using isobutyl chloroformate and a base in the presence of a reaction solvent; and (step 2) preparing a compound represented by chemical formula 1 by removing an amine protective group from the compound represented by chemical formula 4 obtained at step 1. On the reaction scheme, PG is a protective group; X is OR1, where R1 is a lower C1-C5alkyl; HY is a free acid. The invention also relates to a method of producing a compound represented by chemical formula 2, and an intermediate compound used to produce a compound represented by chemical formula 3.
EFFECT: method increases output of dipeptidyl peptidase-IV inhibitor, represented by chemical formula 1.
12 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVED METHOD OF PRODUCING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE COMPOUND | 2010 |
|
RU2499792C2 |
DPP-IV INHIBITOR CONTAINING BETA AMINO GROUP, METHOD FOR MAKING THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING IT FOR PREVENTION AND TREATMENT OF DIABETES OR OBESITY | 2008 |
|
RU2419615C1 |
TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVE SALTS, METHODS FOR PREPARING THEM AND MEDICAL APPLICATION THEREOF | 2010 |
|
RU2523543C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES MELLITUS AND OBESITY CONTAINING COMPOUND INHIBITING ACTIVITY OF DIPEPTIDYLPEPTIDASE-IV, AND OTHER ANTIDIABETIC AGENTS OR ANTIOBESITY AGENTS AS ACTIVE INGREDIENTS | 2009 |
|
RU2466727C1 |
DERIVATIVES OF HEXAHYDRODIAZEPINONE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND USING IN PREPARING MEDICINAL AGENT FOR TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS | 2003 |
|
RU2301803C2 |
HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2756506C2 |
HALOGEN SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2649398C2 |
MORPHOLINE TYPE CINNAMIDE DERIVATIVE | 2006 |
|
RU2381225C1 |
PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND | 2017 |
|
RU2739983C2 |
NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 |
|
RU2474575C2 |
Authors
Dates
2013-11-20—Published
2010-03-30—Filed